The effect of compression therapy using surgical gloves on taxane-induced peripheral neuropathy(randomized control trial)
Phase 2
- Conditions
- lung cancer, gastric cancer, esophageal cancer, breast cancer, endometrial cancer, cervical cancer, ovarian cancer, pancreatic cancer
- Registration Number
- JPRN-UMIN000038056
- Lead Sponsor
- Hitachi general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
patients who have CTCAE more than grade1 neuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of taxane-induced peripheral neuropathy grade 2 or higher using the CTCAE version 5.0.
- Secondary Outcome Measures
Name Time Method The incidence of peripheral neuropathy grade B,C,D,E using Patient Neurotoxicity Questionnairethe (PNQ). The incidence of skin and nail tissue disorders using the CTCAE version 5.0. Time to skin and nail tissue disorders The incidence of taxane-induced peripheral neuropathy grade 1.3.4 using the CTCAE version 5.0. Time to peripheral neuropathy Ratio of cases dropping out